Condensed as-triazine derivatives
US4602018A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 20, 1984 |
| Grant date | Jul 22, 1986 |
| Priority date | — |
| Expiry date | Sep 20, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new condensed as-triazine derivatives of the general Formula I ##STR1## and isomers thereof (wherein R.sub.1 stands for C.sub.1-10 alkyl or phenyl or naphthyl, wherein the two latter groups may be optionally substituted by one or more halogen, nitro, amino, hydroxy, C.sub.1-4 alkyl and/or C.sub.1-4 alkoxy substituent(s); PA0 R.sub.2 is hydrogen, C.sub.1-4 alkyl, hydroxy, halogen or phenyl or naphthyl, wherein the two latter groups may be optionally substituted by one or more halogen, nitro, amino, hydroxy, C.sub.1-4 alkyl and/or C.sub.1-4 alkoxy substituent(s); PA0 R.sub.3 represents hydrogen or C.sub.1-4 alkyl; PA0 Z is buta-1,3-dienyl or a group of the Formula (a) ##STR2## and A.sup.- is an anion). The compounds of the general Formula I possess useful pharmacological properties, particularly antiarrhythmial and antidepressant effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.